S. Chładzińska-Kiejna

Money matters: does the reimbursement policy for second-generation antipsychotics influence the number of recorded schizophrenia patients and the burden of stigmatization?

B. Misiak, D. Frydecka, D. Szcześniak, 2013, Social Psychiatry and Psychiatric Epidemiology.

Whole-body cryotherapy as adjunct treatment of depressive and anxiety disorders

J. Rymaszewska, S. Chładzińska-Kiejna, D. Ramsey, 2008, Archivum Immunologiae et Therapiae Experimentalis.

[Can short-term exposure to extremely low temperatures be used as an adjuvant therapy in the treatment of affective and anxiety disorders?].

J. Rymaszewska, A. Kiejna, S. Chładzińska-Kiejna, 2007, Psychiatria polska.

Coping Styles, Mental Health, and the COVID-19 Quarantine: A Nationwide Survey in Poland

J. Rymaszewska, B. Misiak, D. Szcześniak, 2021, Frontiers in Psychiatry.

European studies on the prevalence of dementia in the elderly: time for a step towards a methodological consensus

B. Misiak, D. Frydecka, A. Kiejna, 2013, International journal of geriatric psychiatry.

Evaluation of the efficacy of ADHD treatment with the use of EEG-biofeedback method in comparison to methylphenidate

T. Adamowski, H. Flisiak-Antonijczuk, S. Chładzińska-Kiejna, 2015 .

Treatment of ADHD: comparison of EEG-biofeedback and methylphenidate

T. Adamowski, H. Flisiak-Antonijczuk, S. Chładzińska-Kiejna, 2015 .